At the time the protocols were finalized, trial results for SURPASS-CVOT were not yet available
People drink more slowly, and the whole experience becomes less pleasurable
Avoid taking greasy, spicy, oily, processed, or sugary foods to reduce the risk of GI side effects
The April 2026 TGA alert regarding unapproved GLP-1 receptor agonists (including Retatrutide) reinforced the distinction between therapeutic use, which remains unapproved, and research-grade supply for laboratory purposes, which is legally distinct under Australian law
If you have genetic predispositions affecting GLP-1 pathway sensitivity or peptide metabolism, consistent medication availability is especially important for safety monitoring and efficacy evaluation
For a researcher without a plateau on tirzepatide, I would not switch on the basis of the current data